Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marjan E. Steenweg is active.

Publication


Featured researches published by Marjan E. Steenweg.


Brain | 2010

Magnetic resonance imaging pattern recognition in hypomyelinating disorders.

Marjan E. Steenweg; Adeline Vanderver; Susan Blaser; Alberto Bizzi; Tom J. de Koning; Grazia M.S. Mancini; Wessel N. van Wieringen; Frederik Barkhof; Nicole I. Wolf; Marjo S. van der Knaap

Hypomyelination is observed in the context of a growing number of genetic disorders that share clinical characteristics. The aim of this study was to determine the possible role of magnetic resonance imaging pattern recognition in distinguishing different hypomyelinating disorders, which would facilitate the diagnostic process. Only patients with hypomyelination of known cause were included in this retrospective study. A total of 112 patients with Pelizaeus-Merzbacher disease, hypomyelination with congenital cataract, hypomyelination with hypogonadotropic hypogonadism and hypodontia, Pelizaeus-Merzbacher-like disease, infantile GM1 and GM2 gangliosidosis, Salla disease and fucosidosis were included. The brain scans were rated using a standard scoring list; the raters were blinded to the diagnoses. Grouping of the patients was based on cluster analysis. Ten clusters of patients with similar magnetic resonance imaging abnormalities were identified. The most important discriminating items were early cerebellar atrophy, homogeneity of the white matter signal on T(2)-weighted images, abnormal signal intensity of the basal ganglia, signal abnormalities in the pons and additional T(2) lesions in the deep white matter. Eight clusters each represented mainly a single disorder (i.e. Pelizaeus-Merzbacher disease, hypomyelination with congenital cataract, hypomyelination with hypogonadotropic hypogonadism and hypodontia, infantile GM1 and GM2 gangliosidosis, Pelizaeus-Merzbacher-like disease and fucosidosis); only two clusters contained multiple diseases. Pelizaeus-Merzbacher-like disease was divided between two clusters and Salla disease did not cluster at all. This study shows that it is possible to separate patients with hypomyelination disorders of known cause in clusters based on magnetic resonance imaging abnormalities alone. In most cases of Pelizaeus-Merzbacher disease, hypomyelination with congenital cataract, hypomyelination with hypogonadotropic hypogonadism and hypodontia, Pelizaeus-Merzbacher-like disease, infantile GM1 and GM2 gangliosidosis and fucosidosis, the imaging pattern gives clues for the diagnosis.


Human Mutation | 2010

An overview of L‐2‐hydroxyglutarate dehydrogenase gene (L2HGDH) variants: a genotype–phenotype study

Marjan E. Steenweg; Cornelis Jakobs; Abdellatif Errami; Silvy J.M. van Dooren; Maria T. Adeva Bartolomé; Peter Aerssens; Persephone Augoustides-Savvapoulou; Ivo Barić; Matthias Baumann; Luisa Bonafé; Brigitte Chabrol; Joe T.R. Clarke; Peter Clayton; Mahmut Çoker; Sarah Cooper; Tzipora C. Falik-Zaccai; Mark P. Gorman; Andreas Hahn; Alev Hasanoglu; Mary D. King; Hans de Klerk; Stanley H. Korman; Céline Lee; Allan M. Lund; Vlatka Mejaški-Bošnjak; Ignacio Pascual-Castroviejo; Aparna Raadhyaksha; Terje Rootwelt; Agathe Roubertie; Maria L. Ruiz-Falco

L‐2‐Hydroxyglutaric aciduria (L2HGA) is a rare, neurometabolic disorder with an autosomal recessive mode of inheritance. Affected individuals only have neurological manifestations, including psychomotor retardation, cerebellar ataxia, and more variably macrocephaly, or epilepsy. The diagnosis of L2HGA can be made based on magnetic resonance imaging (MRI), biochemical analysis, and mutational analysis of L2HGDH. About 200 patients with elevated concentrations of 2‐hydroxyglutarate (2HG) in the urine were referred for chiral determination of 2HG and L2HGDH mutational analysis. All patients with increased L2HG (n=106; 83 families) were included. Clinical information on 61 patients was obtained via questionnaires. In 82 families the mutations were detected by direct sequence analysis and/or multiplex ligation dependent probe amplification (MLPA), including one case where MLPA was essential to detect the second allele. In another case RT‐PCR followed by deep intronic sequencing was needed to detect the mutation. Thirty‐five novel mutations as well as 35 reported mutations and 14 nondisease‐related variants are reviewed and included in a novel Leiden Open source Variation Database (LOVD) for L2HGDH variants (http://www.LOVD.nl/L2HGDH). Every user can access the database and submit variants/patients. Furthermore, we report on the phenotype, including neurological manifestations and urinary levels of L2HG, and we evaluate the phenotype–genotype relationship. Hum Mutat 30:1–11, 2010.


Radiology | 2009

l-2-Hydroxyglutaric Aciduria: Pattern of MR Imaging Abnormalities in 56 Patients

Marjan E. Steenweg; Gajja S. Salomons; Zuhal Yapici; Graziella Uziel; Emmanuel Scalais; Dimitrios I. Zafeiriou; Maria L. Ruiz-Falco; Vlatka Mejaški-Bošnjak; Persephone Augoustides-Savvopoulou; Moacir Wajner; J. H. Walter; Nanda M. Verhoeven-Duif; Eduard A. Struys; Cornelis Jakobs; Marjo S. van der Knaap

PURPOSE To describe the pattern of magnetic resonance (MR) imaging abnormalities in l-2-hydroxyglutaric aciduria (L2HGA) and to evaluate the correlation between imaging abnormalities and disease duration. MATERIALS AND METHODS MR images in 56 patients (30 male, 26 female; mean age +/- standard deviation, 11.9 years +/- 8.5) with genetically confirmed L2HGA were retrospectively reviewed, with institutional review board approval and waiver of informed consent. At least one complete series of transverse T2-weighted images was available for all patients. The images were evaluated by using a previously established scoring list. The correlation between MR imaging abnormalities and disease duration was assessed (Mann-Whitney or Kruskal-Wallis test). RESULTS The cerebral white matter (WM) abnormalities preferentially affected the frontal and subcortical regions. The abnormal subcortical WM often had a mildly swollen appearance (37 patients). Initially, the WM abnormalities were at least partially multifocal (32 patients). In patients with longer disease duration, the WM abnormalities became more confluent and spread centripetally, but the periventricular rim remained relatively spared (41 patients). The mean disease duration in patients with WM atrophy (14.8 years) was significantly longer (P = .001) than that in patients without atrophy (6.7 years). Bilateral involvement of the globus pallidus (55 patients), caudate nucleus (56 patients), and putamen (56 patients) was seen at all stages. The cerebellar WM was never affected. The dentate nucleus was involved bilaterally in 55 of 56 patients. CONCLUSION L2HGA has a distinct highly characteristic pattern of MR imaging abnormalities: a combination of predominantly subcortical cerebral WM abnormalities and abnormalities of the dentate nucleus, globus pallidus, putamen, and caudate nucleus. With increasing disease duration, WM abnormalities and basal ganglia signal intensity abnormalities become more diffuse and cerebral WM atrophy ensues.


Annals of Neurology | 2012

Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging Findings.

Fanny Mochel; Raphael Schiffmann; Marjan E. Steenweg; Hasan O. Akman; Mary Wallace; Frédéric Sedel; P. Laforêt; Richard Levy; J. Michael Powers; Sophie Demeret; Thierry Maisonobe; Roseline Froissart; Bruno Barcelos Da Nobrega; Brent L. Fogel; Marvin R. Natowicz; Catherine Lubetzki; Alexandra Durr; Alexis Brice; Hanna Rosenmann; Varda Barash; Or Kakhlon; J. Moshe Gomori; Marjo S. van der Knaap

Adult polyglucosan body disease (APBD) is an autosomal recessive leukodystrophy characterized by neurogenic bladder, progressive spastic gait, and peripheral neuropathy. Polyglucosan bodies accumulate in the central and peripheral nervous systems and are often associated with glycogen branching enzyme (GBE) deficiency. To improve clinical diagnosis and enable future evaluation of therapeutic strategies, we conducted a multinational study of the natural history and imaging features of APBD.


Clinical Genetics | 2011

Clinical features and X-inactivation in females heterozygous for creatine transporter defect

J.M. van de Kamp; Gms Mancini; Pjw Pouwels; Ofir T. Betsalel; Sjm Van Dooren; I. de Koning; Marjan E. Steenweg; C. Jakobs; M.S. van der Knaap; Gajja S. Salomons

van de Kamp JM, Mancini GMS, Pouwels PJW, Betsalel OT, van Dooren SJM, de Koning I, Steenweg ME, Jakobs C, van der Knaap MS, Salomons GS. Clinical features and X‐inactivation in females heterozygous for creatine transporter defect.


Neuropediatrics | 2012

Early-onset LBSL: How severe does it get?

Marjan E. Steenweg; L van Berge; C. G. M. van Berkel; I.F.M. de Coo; I. K. Temple; Knut Brockmann; C. I. P. Mendonça; S. Vojta; A. Kolk; D. Peck; L. Carr; Graziella Uziel; Annette Feigenbaum; Susan Blaser; Gert C. Scheper; M.S. van der Knaap

AIM Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation (LBSL) is known as a relatively mild leukoencephalopathy. We investigated the occurrence of severe variants of LBSL with extensive brain magnetic resonance imaging (MRI) abnormalities. METHOD MRIs of approximately 3,000 patients with an unknown leukoencephalopathy were retrospectively reviewed for extensive signal abnormalities of the cerebral and cerebellar white matter, posterior limb of the internal capsule, cerebellar peduncles, pyramids, and medial lemniscus. Clinical data were retrospectively collected. RESULTS Eleven patients fulfilled the MRI criteria (six males); six had DARS2 mutations. Clinical and laboratory findings did not distinguish between patients with and without DARS2 mutations, but MRI did. Patients with DARS2 mutations more often had involvement of structures typically affected in LBSL, including decussatio of the medial lemniscus, anterior spinocerebellar tracts, and superior and inferior cerebellar peduncles. Also, involvement of the globus pallidus was associated with DARS2 mutations. Earliest disease onset was neonatal; earliest death at 20 months. INTERPRETATION This study confirms the occurrence of early infantile, severe LBSL, extending the known phenotypic range of LBSL. Abnormality of specific brainstem tracts and cerebellar peduncles are MRI findings that point to the correct diagnosis.


Annals of clinical and translational neurology | 2015

Altered PLP1 splicing causes hypomyelination of early myelinating structures.

Sietske H. Kevelam; Jennifer R. Taube; Rosalina M. L. van Spaendonk; Enrico Bertini; Karen Sperle; Mark A. Tarnopolsky; Davide Tonduti; Enza Maria Valente; Lorena Travaglini; Erik A. Sistermans; Geneviève Bernard; Coriene E. Catsman-Berrevoets; Clara van Karnebeek; John R. Østergaard; Richard L. Friederich; Mahmoud F. Elsaid; Jolanda H. Schieving; Maja Tarailo-Graovac; Simona Orcesi; Marjan E. Steenweg; Carola G.M. van Berkel; Quinten Waisfisz; Truus E. M. Abbink; Marjo S. van der Knaap; Grace M. Hobson; Nicole I. Wolf

The objective of this study was to investigate the genetic etiology of the X‐linked disorder “Hypomyelination of Early Myelinating Structures” (HEMS).


Neuropediatrics | 2012

Characteristics of early MRI in children and adolescents with vanishing white matter.

Hannemieke D. van der Lei; Marjan E. Steenweg; Frederik Barkhof; Ton de Grauw; Marc d'Hooghe; Richard Morton; Siddharth Shah; Nicole I. Wolf; Marjo S. van der Knaap

OBJECTIVE MRI in vanishing white matter typically shows diffuse abnormality of the cerebral white matter, which becomes increasingly rarefied and cystic. We investigated the MRI characteristics preceding this stage. DESIGN In a retrospective observational study, we evaluated all available MRIs in our database of DNA-confirmed VWM patients and selected MRIs without diffuse cerebral white matter abnormalities and without signs of rarefaction or cystic degeneration in patients below 20 years of age. A previously established scoring list was used to evaluate the MRIs. RESULTS An MRI of seven patients fulfilled the criteria. All had confluent and symmetrical abnormalities in the periventricular and bordering deep white matter. In young patients, myelination was delayed. The inner rim of the corpus callosum was affected in all patients. CONCLUSIONS In early stages of VWM, MRI does not necessarily display diffuse cerebral white matter involvement and rarefaction or cystic degeneration. If the MRI abnormalities do not meet the criteria for VWM, it helps to look at the corpus callosum. If the inner rim (the callosal-septal interface) is affected, VWM should be considered.


JAMA Neurology | 2012

Novel infantile-onset leukoencephalopathy with high lactate level and slow improvement.

Marjan E. Steenweg; Adeline Vanderver; Berten Ceulemans; Prab Prabhakar; Luc Régal; Aviva Fattal-Valevski; Lawrence Richer; Barbara Goeggel Simonetti; Frederik Barkhof; Richard J. Rodenburg; Petra J. W. Pouwels; Marjo S. van der Knaap

OBJECTIVE To describe a novel pattern of magnetic resonance imaging (MRI) abnormalities as well as the associated clinical and laboratory findings. DESIGN The MRIs of more than 3000 patients with an unclassified leukoencephalopathy were systematically reviewed.Clinical and laboratory data were retrospectively collected. SETTING University hospital. PATIENTS Seven patients (3 male) shared similar MRI abnormalities and clinical features. MAIN OUTCOME MEASURES Pattern of MRI abnormalities and clinical and laboratory findings. RESULTS The MRIs showed signal abnormalities of the deep cerebral white matter, corpus callosum, thalamus, basal ganglia,brainstem, and cerebellar white matter between the ages of 9 months and 2 years. On follow-up, abnormalities gradually improved. Clinical regression occurred in the second half-year of life with spasticity and loss of milestones.From the second year on, clinical improvement occurred.So far, no second episode of regression has happened.Lactate levels were elevated during clinical regression. CONCLUSION These patients represent a single novel leukoencephalopathy,probably caused by a mitochondrial defect.


JAMA Neurology | 2012

Restricted diffusion in vanishing white matter

Hannemieke D.W. van der Lei; Marjan E. Steenweg; Marianna Bugiani; Petra J. W. Pouwels; Inge M. Vent; Frederik Barkhof; Wessel N. van Wieringen; Marjo S. van der Knaap

OBJECTIVE To investigate the occurrence of restricted diffusion in vanishing white matter, the affected structures,the time of occurrence in the disease course, and the histopathologic correlate. DESIGN Retrospective observational study. PATIENTS Forty-six patients with vanishing white matter. SETTING VU University Medical Center. MAIN OUTCOME MEASURES We evaluated all available diffusion-weighted imaging studies in our database and recorded the areas that displayed restricted diffusion in 1 or more patients. We measured the mean apparent diffusion coefficients of these areas in all patients and used the putamen for internal quality control. We recorded age and disease duration during magnetic resonance imaging, and we obtained a magnetic resonance image of a postmortem vanishing white matter brain slice and subsequently performed histopathologic stainings. RESULTS Areas with decreased apparent diffusion coefficient values were found in the U fibers (n=21 patients), cerebellar white matter (n=18), middle cerebellar peduncle(n=8), pyramids (n=8), genu (n=8) or splenium (n=9) of the corpus callosum, and posterior limb of the internal capsule(n=10). Overall, patients showing restricted diffusion(n=32)were younger and had shorter disease duration. Histopathologic analysis of the brain slice revealed that regions with restricted diffusion had a higher cell density. CONCLUSION In vanishing white matter, restricted diffusion can be found in relatively spared regions with high cellularity particularly in young patients with short disease duration.

Collaboration


Dive into the Marjan E. Steenweg's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nicole I. Wolf

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Frederik Barkhof

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Petra J. W. Pouwels

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

M.S. van der Knaap

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar

Truus E. M. Abbink

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Graziella Uziel

Carlo Besta Neurological Institute

View shared research outputs
Top Co-Authors

Avatar

Adeline Vanderver

Children's Hospital of Philadelphia

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge